Growing Concern about Radiation Dose Exposure
It is estimated that 197,700 new cases of melanoma, 97,920 non-invasive (in situ) and 99,780 invasive, will be diagnosed in the U.S. in 2022.
The Growing Incidence of Cancer is Driving the Growth
The increasing prevalence of cancer is expected to create lucrative growth during the forecast period. Due to alcohol consumption, excessive smoking, and unhealthy lifestyles, cancer is increasing rapidly across the globe. Similarly, growing aging populations are more susceptible to chronic diseases, which in turn boosts the market growth over the years. It Cancer is the second leading cause of death across the world. It's approximate death rate was 9.6 million in 2018. According to GLOBOCAN, in 2012, 14.1 million new cancer cases were diagnosed across the world which increased by 28% to reach 18.1 million new cases in 2018. In the future, treatment costs will increase because of the growing aging population along with the prevalence of different types of cancers.
Rising Demand for Minimally Invasive Procedures
Nearly 20 Americans die from melanoma every day. In 2022, it is estimated that 7,650 deaths will be attributed to melanoma — 5,080 men and 2,570 women
Market Segmentation
Recent Development
The ControlRad device, approved for commercial cath lab use by the FDA in December 2020, is retrofitted to X-ray equipment in the catheterization lab. It creates a type of aperture that collimates the image area being viewed. By using a touch pad attached to the table side rail, the cardiologist controls the aperture to narrow or widen the field of view on the X-ray, reducing the amount of radiation used to produce the images. It works with gloves on.
April 2021 – The American College of Radiology has launched a new digital radiography pilot programme to standardize radiation dose variation in chest exams in order to track and compare radiation dose patterns across healthcare practices using digital radiography.
Market Players
Bayer AG., General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Sectra AB, Medic Vision Imaging Solutions, Agfa-Gevaert Group, Novarad Enterprise Healthcare Solutions, Guerbet are some of the leading players operating in the global radiation dose management market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | · By Product · By Component · By Application · By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled | Bayer AG., General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Sectra AB, Medic Visio Imaging Solutions, Agfa-Gevaert Group, Novarad Enterprise Healthcare Solutions Guerbet |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |